世界の拡張型心筋症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dilated Cardiomyopathy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1896
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、拡張型心筋症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬剤、植込み型除細動器）、用途別市場規模（子供、成人、高齢者）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・拡張型心筋症治療の市場動向
・企業の競争状況、市場シェア
・拡張型心筋症治療の種類別市場規模（薬剤、植込み型除細動器）
・拡張型心筋症治療の用途別市場規模（子供、成人、高齢者）
・拡張型心筋症治療の北米市場規模2016-2027（アメリカ、カナダ）
・拡張型心筋症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・拡張型心筋症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・拡張型心筋症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・拡張型心筋症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Pfizer、Novartis、Merck、Janssen Pharmaceuticals、AstraZeneca、Array BioPharma、Vericel、Celladon、Teva Pharmaceutical Industries）
・結論

Dilated Cardiomyopathy (DCM) is a condition in which heart’s left ventricle, is enlarged and weakened and the ability to pump blood is decreased.
The growth in DCM treatment market is due to prominent rise in number of heart failure patients worldwide over the years, R&D activities and increased awareness for timely diagnosis.

Market Analysis and Insights: Global Dilated Cardiomyopathy Treatment Market
The global Dilated Cardiomyopathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dilated Cardiomyopathy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dilated Cardiomyopathy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dilated Cardiomyopathy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dilated Cardiomyopathy Treatment market.

Global Dilated Cardiomyopathy Treatment Scope and Market Size
Dilated Cardiomyopathy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dilated Cardiomyopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Implantable Devices

Segment by Application
Child
Adult
Elderly

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Pfizer
Novartis
Merck
Janssen Pharmaceuticals
AstraZeneca
Array BioPharma
Vericel
Celladon

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dilated Cardiomyopathy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Implantable Devices
1.3 Market by Application
1.3.1 Global Dilated Cardiomyopathy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dilated Cardiomyopathy Treatment Market Perspective (2016-2027)
2.2 Dilated Cardiomyopathy Treatment Growth Trends by Regions
2.2.1 Dilated Cardiomyopathy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dilated Cardiomyopathy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dilated Cardiomyopathy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dilated Cardiomyopathy Treatment Industry Dynamic
2.3.1 Dilated Cardiomyopathy Treatment Market Trends
2.3.2 Dilated Cardiomyopathy Treatment Market Drivers
2.3.3 Dilated Cardiomyopathy Treatment Market Challenges
2.3.4 Dilated Cardiomyopathy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dilated Cardiomyopathy Treatment Players by Revenue
3.1.1 Global Top Dilated Cardiomyopathy Treatment Players by Revenue (2016-2021)
3.1.2 Global Dilated Cardiomyopathy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dilated Cardiomyopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dilated Cardiomyopathy Treatment Revenue
3.4 Global Dilated Cardiomyopathy Treatment Market Concentration Ratio
3.4.1 Global Dilated Cardiomyopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dilated Cardiomyopathy Treatment Revenue in 2020
3.5 Dilated Cardiomyopathy Treatment Key Players Head office and Area Served
3.6 Key Players Dilated Cardiomyopathy Treatment Product Solution and Service
3.7 Date of Enter into Dilated Cardiomyopathy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dilated Cardiomyopathy Treatment Breakdown Data by Type
4.1 Global Dilated Cardiomyopathy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dilated Cardiomyopathy Treatment Forecasted Market Size by Type (2022-2027)

5 Dilated Cardiomyopathy Treatment Breakdown Data by Application
5.1 Global Dilated Cardiomyopathy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dilated Cardiomyopathy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dilated Cardiomyopathy Treatment Market Size (2016-2027)
6.2 North America Dilated Cardiomyopathy Treatment Market Size by Type
6.2.1 North America Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021)
6.2.2 North America Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027)
6.2.3 North America Dilated Cardiomyopathy Treatment Market Size by Type (2016-2027)
6.3 North America Dilated Cardiomyopathy Treatment Market Size by Application
6.3.1 North America Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021)
6.3.2 North America Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027)
6.3.3 North America Dilated Cardiomyopathy Treatment Market Size by Application (2016-2027)
6.4 North America Dilated Cardiomyopathy Treatment Market Size by Country
6.4.1 North America Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021)
6.4.2 North America Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dilated Cardiomyopathy Treatment Market Size (2016-2027)
7.2 Europe Dilated Cardiomyopathy Treatment Market Size by Type
7.2.1 Europe Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dilated Cardiomyopathy Treatment Market Size by Type (2016-2027)
7.3 Europe Dilated Cardiomyopathy Treatment Market Size by Application
7.3.1 Europe Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dilated Cardiomyopathy Treatment Market Size by Application (2016-2027)
7.4 Europe Dilated Cardiomyopathy Treatment Market Size by Country
7.4.1 Europe Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Type
8.2.1 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Application
8.3.1 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Region
8.4.1 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dilated Cardiomyopathy Treatment Market Size (2016-2027)
9.2 Latin America Dilated Cardiomyopathy Treatment Market Size by Type
9.2.1 Latin America Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dilated Cardiomyopathy Treatment Market Size by Type (2016-2027)
9.3 Latin America Dilated Cardiomyopathy Treatment Market Size by Application
9.3.1 Latin America Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dilated Cardiomyopathy Treatment Market Size by Application (2016-2027)
9.4 Latin America Dilated Cardiomyopathy Treatment Market Size by Country
9.4.1 Latin America Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Type
10.2.1 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Application
10.3.1 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Country
10.4.1 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Dilated Cardiomyopathy Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Dilated Cardiomyopathy Treatment Introduction
11.2.4 Pfizer Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dilated Cardiomyopathy Treatment Introduction
11.3.4 Novartis Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Dilated Cardiomyopathy Treatment Introduction
11.4.4 Merck Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Details
11.5.2 Janssen Pharmaceuticals Business Overview
11.5.3 Janssen Pharmaceuticals Dilated Cardiomyopathy Treatment Introduction
11.5.4 Janssen Pharmaceuticals Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.5.5 Janssen Pharmaceuticals Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Dilated Cardiomyopathy Treatment Introduction
11.6.4 AstraZeneca Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Array BioPharma
11.7.1 Array BioPharma Company Details
11.7.2 Array BioPharma Business Overview
11.7.3 Array BioPharma Dilated Cardiomyopathy Treatment Introduction
11.7.4 Array BioPharma Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.7.5 Array BioPharma Recent Development
11.8 Vericel
11.8.1 Vericel Company Details
11.8.2 Vericel Business Overview
11.8.3 Vericel Dilated Cardiomyopathy Treatment Introduction
11.8.4 Vericel Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.8.5 Vericel Recent Development
11.9 Celladon
11.9.1 Celladon Company Details
11.9.2 Celladon Business Overview
11.9.3 Celladon Dilated Cardiomyopathy Treatment Introduction
11.9.4 Celladon Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.9.5 Celladon Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Details
11.10.2 Teva Pharmaceutical Industries Business Overview
11.10.3 Teva Pharmaceutical Industries Dilated Cardiomyopathy Treatment Introduction
11.10.4 Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dilated Cardiomyopathy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Implantable Devices
Table 4. Global Dilated Cardiomyopathy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dilated Cardiomyopathy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dilated Cardiomyopathy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dilated Cardiomyopathy Treatment Market Share by Regions (2016-2021)
Table 8. Global Dilated Cardiomyopathy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dilated Cardiomyopathy Treatment Market Share by Regions (2022-2027)
Table 10. Dilated Cardiomyopathy Treatment Market Trends
Table 11. Dilated Cardiomyopathy Treatment Market Drivers
Table 12. Dilated Cardiomyopathy Treatment Market Challenges
Table 13. Dilated Cardiomyopathy Treatment Market Restraints
Table 14. Global Dilated Cardiomyopathy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dilated Cardiomyopathy Treatment Market Share by Players (2016-2021)
Table 16. Global Top Dilated Cardiomyopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Treatment as of 2020)
Table 17. Ranking of Global Top Dilated Cardiomyopathy Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dilated Cardiomyopathy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dilated Cardiomyopathy Treatment Product Solution and Service
Table 21. Date of Enter into Dilated Cardiomyopathy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dilated Cardiomyopathy Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Dilated Cardiomyopathy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dilated Cardiomyopathy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dilated Cardiomyopathy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dilated Cardiomyopathy Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Dilated Cardiomyopathy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dilated Cardiomyopathy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Dilated Cardiomyopathy Treatment Product
Table 64. GlaxoSmithKline Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Dilated Cardiomyopathy Treatment Product
Table 69. Pfizer Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Dilated Cardiomyopathy Treatment Product
Table 74. Novartis Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Dilated Cardiomyopathy Treatment Product
Table 79. Merck Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Janssen Pharmaceuticals Company Details
Table 82. Janssen Pharmaceuticals Business Overview
Table 83. Janssen Pharmaceuticals Dilated Cardiomyopathy Treatment Product
Table 84. Janssen Pharmaceuticals Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 85. Janssen Pharmaceuticals Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Dilated Cardiomyopathy Treatment Product
Table 89. AstraZeneca Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Array BioPharma Company Details
Table 92. Array BioPharma Business Overview
Table 93. Array BioPharma Dilated Cardiomyopathy Treatment Product
Table 94. Array BioPharma Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 95. Array BioPharma Recent Development
Table 96. Vericel Company Details
Table 97. Vericel Business Overview
Table 98. Vericel Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 99. Vericel Recent Development
Table 100. Celladon Company Details
Table 101. Celladon Business Overview
Table 102. Celladon Dilated Cardiomyopathy Treatment Product
Table 103. Celladon Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 104. Celladon Recent Development
Table 105. Teva Pharmaceutical Industries Company Details
Table 106. Teva Pharmaceutical Industries Business Overview
Table 107. Teva Pharmaceutical Industries Dilated Cardiomyopathy Treatment Product
Table 108. Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Treatment Business (2016-2021) & (US$ Million)
Table 109. Teva Pharmaceutical Industries Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dilated Cardiomyopathy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Implantable Devices Features
Figure 4. Global Dilated Cardiomyopathy Treatment Market Share by Application: 2020 VS 2027
Figure 5. Child Case Studies
Figure 6. Adult Case Studies
Figure 7. Elderly Case Studies
Figure 8. Dilated Cardiomyopathy Treatment Report Years Considered
Figure 9. Global Dilated Cardiomyopathy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dilated Cardiomyopathy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dilated Cardiomyopathy Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Dilated Cardiomyopathy Treatment Market Share by Regions (2022-2027)
Figure 13. Global Dilated Cardiomyopathy Treatment Market Share by Players in 2020
Figure 14. Global Top Dilated Cardiomyopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dilated Cardiomyopathy Treatment Revenue in 2020
Figure 16. Global Dilated Cardiomyopathy Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Dilated Cardiomyopathy Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dilated Cardiomyopathy Treatment Market Share by Type (2016-2027)
Figure 20. North America Dilated Cardiomyopathy Treatment Market Share by Application (2016-2027)
Figure 21. North America Dilated Cardiomyopathy Treatment Market Share by Country (2016-2027)
Figure 22. United States Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dilated Cardiomyopathy Treatment Market Share by Type (2016-2027)
Figure 26. Europe Dilated Cardiomyopathy Treatment Market Share by Application (2016-2027)
Figure 27. Europe Dilated Cardiomyopathy Treatment Market Share by Country (2016-2027)
Figure 28. Germany Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dilated Cardiomyopathy Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dilated Cardiomyopathy Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dilated Cardiomyopathy Treatment Market Share by Region (2016-2027)
Figure 38. China Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dilated Cardiomyopathy Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Dilated Cardiomyopathy Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Dilated Cardiomyopathy Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dilated Cardiomyopathy Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dilated Cardiomyopathy Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dilated Cardiomyopathy Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dilated Cardiomyopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 61. Janssen Pharmaceuticals Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 63. Array BioPharma Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 64. Vericel Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 65. Celladon Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Dilated Cardiomyopathy Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5731 2021年4月 91Pages
QYResearch社発行の本調査資料では、トランスサイレチンアミロイド心筋症（ATTR-CM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トランスサイレチン安定剤、非ステロイド性抗炎症薬（NSAID）、RNAi療法、その他）、用途別市...

世界の心筋症市場規模・現状・予測（2021年-2027年）

Global Cardiomyopathy Market Size, Status and Forecast 2021-2027
QYR2104Z1129 2021年4月 95Pages
QYResearch社発行の本調査資料では、心筋症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（拡張型心筋症、肥大型心筋症、拘束型心筋症）、用途別市場規模（病院・診断センター、外来サービスセンター）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の心筋症装置市場規模・現状・予測（2021年-2027年）

Global Cardiomyopathy Devices Market Size, Status and Forecast 2021-2027
QYR2104Z1128 2021年4月 94Pages
QYResearch社発行の本調査資料では、心筋症装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断装置、治療装置）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界の肥大型心筋症治療市場規模・現状・予測（2021年-2027年）

Global Hypertrophic Cardiomyopathy Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3004 2021年4月 94Pages
QYResearch社発行の本調査資料では、肥大型心筋症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルシウムチャネル遮断薬、抗不整脈薬、βアドレナリン遮断薬、抗凝固薬、その他）、用途別市場規模（病院、診療所、外来手術センター、学術・研...

世界の肥大型心筋症（HCM）治療市場規模・現状・予測（2021年-2027年）

Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3003 2021年4月 98Pages
QYResearch社発行の本調査資料では、肥大型心筋症（HCM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（βアドレナリン遮断薬、カルシウムチャネル遮断薬、抗不整脈薬、抗凝固薬、その他）、用途別市場規模（病院薬局、小売薬局）、主要地域...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のトランスサイレチンアミロイド心筋症（ATTR-CM）治療市場規模・現状・予測（2021年-2027年） Transthyretin Amyloidosis (ATTR) is a progressive and severe orphan disease. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of transthyretin amyloidosis (ATTR) that affects the heart and leads to restrictive cardiomyopathy and progressive heart failure. It is generally a rare, underdiagnos…
世界の心筋症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cardiomyopathy Market The global Cardiomyopathy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
世界の心筋症装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cardiomyopathy Devices Market The global Cardiomyopathy Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の肥大型心筋症治療市場規模・現状・予測（2021年-2027年） HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
世界の肥大型心筋症（HCM）治療市場規模・現状・予測（2021年-2027年） Hypertrophic Cardiomyopathy (HCM) is a condition in which a portion of the heart becomes thickened without an obvious cause. This results in the heart being less able to pump blood effectively. Symptoms vary from none to feeling tired, leg swelling, and shortness of breath. It may also result in che…